Education
About Us
Working with TipRanks
Follow Us
Predictive Oncology Inc (POAI)
NASDAQ:POAI
POAI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.55 - $3.06
Previous CloseN/A
Volume663.11K
Average Volume (3M)168.14K
Market Cap
$8.18M
Enterprise Value$7.01M
Total Cash (Recent Filing)$3.09M
Total Debt (Recent Filing)$1.92M
Price to Earnings (P/E)―
Beta1.21
Next Earnings
Aug 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.34
Shares Outstanding10,222,221
10 Day Avg. Volume200,392
30 Day Avg. Volume168,136
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)-39.25
Price to Sales (P/S)0.00
P/FCF Ratio-0.96
Enterprise Value/Market Cap0.86
Enterprise Value/Revenue2.99
Enterprise Value/Gross Profit22.15
Enterprise Value/Ebitda-0.31
Forecast
1Y Price Target
$1.00Price Target Upside25.00% Upside
Rating ConsensusHold
Number of Analyst Covering0
Predictive Oncology News
PremiumCompany Announcements
Predictive Oncology Granted Nasdaq Compliance Extension
PremiumCompany Announcements
Predictive Oncology Sells Eagan Business to DeRoyal
PremiumCompany Announcements
Predictive Oncology Faces Nasdaq Non-Compliance Notice
PremiumCompany Announcements
Predictive Oncology Finalizes Stock Exchange Purchase Agreement
Bulls Say, Bears Say
Bulls Say
TechnologyThe proprietary AI platform PEDAL has demonstrated the potential to identify biomarkers in cancer patients, making it an attractive licensing target.
Bears Say
Financial PerformancePredictive Oncology reported lower than expected revenue for 3Q24, indicating potential financial challenges.
Strategic UncertaintyThe company is undergoing a strategic review, which includes evaluating alternatives like a sale of the company or its assets, creating uncertainty.
Options Prices
Currently, No data available
---
Ownership Overview
1.57% Insiders
1.24% Mutual Funds
0.11% Other Institutional Investors
97.93% Public Companies and
Individual Investors
POAI FAQ
What was Predictive Oncology Inc’s price range in the past 12 months?
Predictive Oncology Inc lowest stock price was $0.55 and its highest was $3.06 in the past 12 months.
What is Predictive Oncology Inc’s market cap?
Predictive Oncology Inc’s market cap is $8.18M.
When is Predictive Oncology Inc’s upcoming earnings report date?
Predictive Oncology Inc’s upcoming earnings report date is Aug 07, 2025 which is in 8 days.
How were Predictive Oncology Inc’s earnings last quarter?
Predictive Oncology Inc released its earnings results on May 15, 2025. The company reported -$0.34 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.34.
Is Predictive Oncology Inc overvalued?
According to Wall Street analysts Predictive Oncology Inc’s price is currently Undervalued.
Does Predictive Oncology Inc pay dividends?
Predictive Oncology Inc does not currently pay dividends.
What is Predictive Oncology Inc’s EPS estimate?
Predictive Oncology Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Predictive Oncology Inc have?
Predictive Oncology Inc has 10,222,221 shares outstanding.
What happened to Predictive Oncology Inc’s price movement after its last earnings report?
Predictive Oncology Inc reported an EPS of -$0.34 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.804%.
Which hedge fund is a major shareholder of Predictive Oncology Inc?
Currently, no hedge funds are holding shares in POAI
Company Description
Predictive Oncology Inc
Predictive Oncology (POAI) is a biotechnology company focused on the development of innovative solutions in the field of cancer research and treatment. The company leverages artificial intelligence (AI) and machine learning to enhance the precision and effectiveness of oncology therapies. POAI operates across multiple sectors, including drug discovery, personalized medicine, and biopharmaceutical research, providing advanced tools and technologies to improve patient outcomes.